All Stories

  1. Chemotherapy for metastatic testicular cancer: The first nationwide multi-institutional study by the Cancer Registration Committee of the Japanese Urological Association

    Article • International Journal of Urology, July 2018, Wiley

    Dr Terukazu Nakamura

  2. Therapy-related acute myeloid leukemia and myelodysplastic syndrome among refractory germ cell tumor patients

    Article • International Journal of Urology, May 2018, Wiley

    Dr Terukazu Nakamura, Yuta Inoue

  3. Editorial Comment from Dr Nakamura to Identification of a subgroup with worse prognosis among patients with poor-risk testicular germ cell tumor

    Article • International Journal of Urology, July 2015, Wiley

    Dr Terukazu Nakamura

  4. Clinical outcomes and histological findings of patients with advanced metastatic germ cell tumors undergoing post-chemotherapy resection of retroperitoneal lymph nodes and residual extraretroperitoneal masses

    Article • International Journal of Urology, April 2015, Wiley

    Dr Terukazu Nakamura

  5. sequential chemotherapy for advanced testicular cancer

    Article • Medicine, March 2015, Wolters Kluwer Health

    Dr Terukazu Nakamura

  6. Salvage combined chemotherapy with paclitaxel, ifosfamide and nedaplatin for patients with advanced germ cell tumors

    Article • International Journal of Urology, November 2014, Wiley

    Dr Terukazu Nakamura

  7. Experience of Laparoscopic Partial Nephrectomy Using a Kidney Grasper in Selective Cases

    Article • Journal of Laparoendoscopic & Advanced Surgical Techniques, November 2014, Mary Ann Liebert Inc

    Dr Terukazu Nakamura

  8. CDK1 and CDK2 activity is a strong predictor of renal cell carcinoma recurrence

    Article • Urologic Oncology Seminars and Original Investigations, November 2014, Elsevier

    Dr Terukazu Nakamura

  9. Initial experience of combined use of photodynamic diagnosis and narrow band imaging for detection of flat urothelial lesion

    Article • International Journal of Clinical Oncology, September 2014, Springer Science + Business Media

    Dr Terukazu Nakamura

  10. Complete response of sunitinib therapy for renal cell cancer recurrence in the native kidney after renal transplantation: a case report

    Article • BMC Research Notes, August 2014, Springer Science + Business Media

    Dr Terukazu Nakamura

  11. Long-term outcome of hand-assisted laparoscopic radical nephrectomy for T1 renal cell carcinoma

    Article • International Journal of Urology, July 2014, Wiley

    Dr Terukazu Nakamura

  12. Comparison of diameter-axial-polar nephrometry and RENAL nephrometry score for treatment decision-making in patients with small renal mass

    Article • International Journal of Clinical Oncology, June 2014, Springer Science + Business Media

    Dr Terukazu Nakamura

  13. Post-chemotherapy nerve-sparing laparoscopic retroperitoneal lymph node dissection in stage IIB testicular cancer

    Article • International Journal of Urology, January 2013, Wiley

    Dr Terukazu Nakamura

  14. Efficacy of Goshajinkigan for Oxaliplatin-Induced Peripheral Neuropathy in Colorectal Cancer Patients

    Article • Journal of Oncology, January 2013, Hindawi Publishing Corporation

    Dr Terukazu Nakamura

  15. High mobility group protein AT-hook 1 (HMGA1) is associated with the development of androgen independence in prostate cancer cells

    Article • The Prostate, December 2011, Wiley

    Dr Terukazu Nakamura

  16. Recent strategy for the management of advanced testicular cancer

    Article • International Journal of Urology, February 2010, Wiley

    Dr Terukazu Nakamura

  17. Radiofrequency ablation for renal tumors: Our experience

    Article • International Journal of Urology, November 2009, Wiley

    Dr Terukazu Nakamura

  18. Brain metastases from testicular germ cell tumors: A retrospective analysis

    Article • International Journal of Urology, November 2009, Wiley

    Dr Terukazu Nakamura

  19. Salvage chemotherapy with paclitaxel and gemcitabine plus nedaplatin (TGN) as part of multidisciplinary therapy in patients with heavily pretreated cisplatin-refractory germ cell tumors

    Article • International Journal of Clinical Oncology, October 2009, Springer Science + Business Media

    Dr Terukazu Nakamura

  20. Post-chemotherapy nerve-sparing retroperitoneal lymph node dissection for advanced germ cell tumor

    Article • International Journal of Urology, February 2009, Wiley

    Dr Terukazu Nakamura

  21. LIPOXYGENASE INHIBITORS INDUCE DEATH RECEPTOR 5/TRAIL-R2 EXPRESSION AND SENSITIZE THE DU145 HUMAN PROSTATE CANCER CELL LINE TO TRAIL-INDUCED APOPTOSIS

    Article • The Journal of Urology, April 2008, Elsevier

    Dr Terukazu Nakamura

  22. Overexpression of XIAP expression in renal cell carcinoma predicts a worse prognosis

    Article • International Journal of Oncology, April 2007, Spandidos Publications

    Dr Terukazu Nakamura

  23. Multiple promoters regulate tissue-specific alternative splicing of the human kallikrein gene, KLK11/hippostasin

    Article • FEBS Journal, August 2006, Wiley

    Dr Terukazu Nakamura

  24. Improved prostate cancer detection with a human kallikrein 11 and percentage free PSA-based artificial neural network

    Article • Biological Chemistry, June 2006, De Gruyter

    Dr Terukazu Nakamura, Professor Klaus Jung

  25. Three new serum markers for prostate cancer detection within a percent free PSA-based artificial neural network

    Article • The Prostate, May 2006, Wiley

    Dr Terukazu Nakamura, Professor Klaus Jung

  26. Serum human glandular kallikrein 2 (hK2) for distinguishing stage and grade of prostate cancer

    Article • International Journal of Urology, March 2006, Wiley

    Dr Terukazu Nakamura, Professor Klaus Jung

  27. Complexed PSA improves prostate cancer detection: Results from a multicenter Japanese clinical trial

    Article • Urology, February 2006, Elsevier

    Dr Terukazu Nakamura

  28. Human tissue kallikrein 9: production of recombinant proteins and specific antibodies

    Article • Biological Chemistry, January 2006, De Gruyter

    Dr Terukazu Nakamura

  29. Clinical characteristics of prostate cancer in Japanese men in the eras before and after serum prostate-specific antigen testing

    Article • International Journal of Urology, July 2005, Wiley

    Dr Terukazu Nakamura

  30. Radio-frequency ablation of renal cell carcinoma in patients who were at significant risk

    Article • International Journal of Urology, December 2004, Wiley

    Dr Terukazu Nakamura

  31. Can Complexed Prostate Specific Antigen Enhance Prostate Cancer Detection in Japanese Men?

    Article • European Urology, July 2004, Elsevier

    Dr Terukazu Nakamura

  32. Hepsin is Highly Over Expressed in and a New Candidate for a Prognostic Indicator in Prostate Cancer

    Article • The Journal of Urology, January 2004, Elsevier

    Dr Terukazu Nakamura, Professor Klaus Jung

  33. Quantitative analysis of hippostasin/KLK11 gene expression in cancerous and noncancerous prostatic tissues

    Article • Urology, May 2003, Elsevier

    Dr Terukazu Nakamura, Professor Klaus Jung

  34. The Prognostic Value of the Human Kallikrein Gene 9 (KLK9) in Breast Cancer

    Article • Breast Cancer Research and Treatment, March 2003, Springer Science + Business Media

    Dr Terukazu Nakamura

  35. Molecular cloning and expression of a variant form of hippostasin/KLK11 in prostate

    Article • The Prostate, January 2003, Wiley

    Dr Terukazu Nakamura

  36. Experience of radio-frequency ablation for renal cell carcinoma in patients with general or renal risks for standard renal surgery

    Article • Journal of Microwave Surgery, January 2003, Study Group of Microwave Surgery

    Dr Terukazu Nakamura

  37. Quantitative Analysis of Kallikrein 15 Gene Expression in Prostate Tissue

    Article • The Journal of Urology, January 2003, Elsevier

    Dr Terukazu Nakamura, Professor Klaus Jung

  38. Quantitative Analysis of Kallikrein 15 Gene Expression in Prostate Tissue

    Article • The Journal of Urology, January 2003, Elsevier

    Dr Terukazu Nakamura

  39. Alternative splicing isoforms of hippostasin (PRSS20/KLK11) in prostate cancer cell lines

    Article • The Prostate, January 2001, Wiley

    Dr Terukazu Nakamura